The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJPB.L Regulatory News (JPB)

  • There is currently no data for JPB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Results to 31 October 2018

13 Dec 2018 16:03

RNS Number : 4434K
JPMorgan Brazil Investment Trust
13 December 2018
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

JPMORGAN BRAZIL INVESTMENT TRUST PLC

UNAUDITED HALF YEAR RESULTS FOR THE SIX MONTHS ENDED31ST OCTOBER 2018

 

Legal Entity Identifier: 5493002T5BE3YCTKTE20

Information disclosed in accordance with DTR 4.2.2

 

CHAIRMAN'S STATEMENT

Introduction and Performance

During the first six months of the financial year to 31st October 2018, Brazilian equities were very volatile. The Company recorded a total return on net assets for the reporting period of -1.2%, whereas the benchmark, the MSCI 10/40 Index (in sterling terms) recorded a return of +3.7% for the same period. The share price return to Ordinary shareholders was -4.4%, reflecting the widening of the share price discount to net asset value. At 31st October 2018, the share price was trading at a discount of 17.0%, compared to 14.0% as at 30th April 2018.

The underperformance was largely attributable to sector allocation, most significantly in the consumer discretionary and energy sectors. The investment managers do not focus significantly on commodity companies, which were the key value drivers of the rally in Latin America during the reporting period.

The Investment Managers' Report gives a more detailed commentary about the markets and conditions experienced during this period and the outlook for the remainder of the financial year.

Since the period end, the Company's NAV has remained level as at the time of writing, but the share price has fallen by 3.6% as discounts have widened across the sector.

Share repurchases

During the six months to 31st October 2018, the Company did not repurchase any shares. The Board will continue to monitor the absolute level of discount at which the share price trades relative to NAV and the volatility of the discount. Since 1st May 2018, the share price discount to NAV to date has ranged between 7.5% and 21.6%, averaging 14.9%.

Outlook

The outcome of the recent presidential election was generally considered to be favourable to Brazilian business. The market has reacted positively to the political agenda of the new president and to his principal ministerial appointments. It is hoped that the new government will pursue the reforms that are essential to improve the economic outlook; however, it may be difficult to gather the necessary congressional and public support for the successful implementation of the reforms. This uncertainty, the direction of the dollar and the ongoing trade tensions between the US and China may cause investors to be cautious. However, Brazil's stock valuations appear attractive following the selloff earlier this year and given the potential for higher earnings that the market expects over the medium term. The Board continues to believe that the outlook for Brazil can be positive provided that there is real progress on the pensions and social security reforms. The investment managers' strategy remains focussed on high-quality stocks with good prospects.

 

Howard Myles

Chairman 13th December 2018

 

INVESTMENT MANAGERS' REPORT

Market review

The six months period to 31st October 2018 saw significant volatility in the price of Brazilian equities, with the Company's benchmark index, the MSCI Brazil 10/40 Index, ultimately returning 3.7% (in sterling terms) for the period.

In May, the much publicised strike by truck drivers, accompanied by road blocks, led to shortages of supplies and froze production in all areas of the economy. As a result, industrial production suffered a double digit decline of 10.9%, one of the biggest monthly declines in recent decades. This event, combined with worsening financial

 

conditions in the market as a result of both domestic and external factors (namely the October elections and a less favourable environment for equities) weighed on the economy. By September a degree of calm began to return to the markets as it became clearer that the front runners with presidential potential were the right-wing Jair Bolsonaro of the Social Liberal Party and left-wing Fernando Haddad of the Workers' Party. The positive performance continued following Bolsonaro's win in the presidential elections. However, overall the economy showed signs of weakness with growth revised downwards. Expectations for company earnings were also lowered. As noted above, GDP figures for the third quarter were affected by May's truck drivers' strike which led to significant business slowdowns. In addition, since August, the Brazilian currency has suffered a steep double-digit depreciation in common with many other emerging markets currencies.

Portfolio review

Against this backdrop, the Company's net asset value and share price returned -1.2% and -4.4% respectively during the review period, lagging its respective index, the MSCI Brazil 10/40 (in sterling terms). Sector allocation was the key detractor, notably in consumer discretionary and energy. As a reminder, we tend to be underweight some commodity companies as they do not fit our growth focused investment strategy. However, these stocks were and continue to be the drivers of the value rally in Latin America, notably Petrobras, which rose as Bolsonaro's election victory relieved concerns of policy risk that had been priced into the stock

Our holding in Fleury, an operator of clinical laboratories in Brazil, detracted from returns. The stock has come under pressure as companies re-examine their healthcare costs which have continued to rise during the recession. There is also uncertainty around potential industry changes, and how it might affect Fleury, as more companies think about preventative medicine options. However, we expect the company to deliver over the medium and long-term and therefore have maintained our holding.

Also detracting from results was our position in Raia Drogasil, a Brazilian drug store operator. The company announced weaker-than-expected 3Q results. Despite the more challenging short term environment, the message given by management and the Board is very clear; their focus is on taking steps to create long term value.

In terms of positive contributors to performance, our exposure to Lojas Renner, a leading department store retailer, was key. Whilst the stock suffered a de-rating with the rest of consumer discretionary companies it continued to deliver good growth. We added to the position in early September after the fall in share price in August. Our belief in the stock was rewarded as the price subsequently increased strongly on the announcement that the Board had approved a CEO succession plan. Fabio Faccio will be stepping into the CEO role in April 2019. We view the transition as confirmation of the company's strong corporate governance.

Also of note was Cielo, Brazil's largest credit and debit card operator. The company missed earnings targets as a result of higher-than-expected marketing costs and competition which negatively impacted profitability. We have reduced our exposure to this name to zero and therefore this was a positive contributor to relative performance.

Our exposure to non-Brazil stocks was 3.57%. The sole exposure in Argentina, MercadoLibre (1.39%), an e-commerce and payments company operating across LATAM with over 200 million users, was positive. The market was encouraged by their proposed move away from relying on Correios for deliveries to an internal network and the strong growth which has started to be seen in their off marketplace payments business.

In terms of changes to the portfolio, we reduced our position in Linx, a management software company. We have less visibility and conviction in the growth dynamics of the company given its move into new sales areas. We also exited our position in BB Seguridade, a financials name. Although the stock is trading at relatively inexpensive valuations, we believe the financial penetration trend which provided a tailwind to the stock performance has matured. The sale proceeds were rotated into a position in Via Varejo, a white-goods retailer where we increased our exposure in the belief that the company is well positioned to deliver strong results over the short-term. In addition, we believe it is trading cheaply to its competitor, Magazine Luisa. We also increased our exposure to Localiza, a car rental company.

Our exposure continues to remain tilted in favour of domestic themes, especially domestic cyclicals, in anticipation of stronger growth over the coming months.

 

 

 

 

 

PERFORMANCE ATTRIBUTION

FOR THE SIX MONTHS ENDED 31ST OCTOBER 2018

%

%

Contributions to total returns

Benchmark return (in sterling terms)

3.7

Asset allocation

-1.0

Stock selection

-3.1

Gearing/cash

0.2

Investment manager contribution

-3.9

Portfolio return

-0.2

Management fee/other expenses

-1.0

Return on net assets

-1.2

Impact of change in discount

-3.2

Return to shareholders

-4.4

Source: Factset/Datastream/Morningstar. All figures are on a total return basis.

Performance attribution analyses how the Company achieved its recorded performance relative to its benchmark.

A glossary of terms and alternative performance measures is provided on page 24 of the half year report.

 

Outlook

The selloff in emerging market stocks this year has led to valuations that are increasingly attractive relative to historical valuations, particularly considering the forecast double-digit earnings growth for the next 12 months.

The near-term path of markets will likely depend on whether the dollar continues to rally and the market's views on the likelihood of agreement between the US and China on trade.

The uncertainty around the election outcome has finally ended following Jair Bolsonaro's win at the end of October. The focus is now on the new president's ability to deliver on his promises of privatisation and pension reform, amongst other things, and we believe that the appointments made to date to his team and to state companies will be positive in this regard. We will continue to keep an eye on key economic indicators including industrial production, retail sales and consumer confidence. Brazil's markets rallied significantly following the first round of the presidential election in October, but further gains will depend on the ability of the government to deliver comprehensive reforms.

Our portfolio includes long-standing, high-quality companies and we are positioned for a recovery in the economy.

Luis Carrillo

Sophie Bosch De Hood

Investment Managers 13th December 2018

 

INTERIM MANAGEMENT REPORT

The Company is required to make the following disclosures in its half year report:

Principal Risks and Uncertainties

The principal risks and uncertainties faced by the Company have not changed and fall into the following broad categories: investment and strategy; market; accounting, legal and regulatory; corporate governance and shareholder relations; operational and financial. Information on each of these areas is given in the Directors' Report within the Annual Report and Accounts for the year ended 30th April 2018.

Related Parties Transactions

During the first six months of the current financial year, no transactions with related parties have taken place which have materially affected the financial position or the performance of the Company.

Going Concern

The Directors believe, having considered the Company's investment objectives, risk management policies, capital management policies and procedures, nature of the portfolio and expenditure projections, that the Company has adequate resources, an appropriate financial structure and suitable management arrangements in place to continue in operational existence for the foreseeable future and, more specifically, that there are no material uncertainties pertaining to the Company that would prevent its ability to continue in such operation existence for at least twelve months from the date of the approval of this half yearly financial report. For these reasons, they consider there is reasonable evidence to continue to adopt the going concern basis in preparing the accounts.

Directors' Responsibilities

The Board of Directors confirms that, to the best of its knowledge:

(i) the condensed set of financial statements contained within the half yearly financial report has been prepared in accordance with FRS 104 'Interim Financial Reporting' and gives a true and fair view of the state of affairs of the Company and of the assets, liabilities, financial position and net return of the Company, as at 31st October 2018, as required by the UK Listing Authority Disclosure and Transparency Rules 4.2.4R; and

(ii) the interim management report includes a fair review of the information required by 4.2.7R and 4.2.8R of the UK Listing Authority Disclosure and Transparency Rules.

In order to provide these confirmations, and in preparing these financial statements, the Directors are required to:

• select suitable accounting policies and then apply them consistently;

• make judgements and accounting estimates that are reasonable and prudent;

• state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

• prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business;

and the Directors confirm that they have done so.

 

For and on behalf of the Board

Howard Myles

Chairman 13th December 2018

STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED 31ST OCTOBER 2018

(Unaudited)

(Unaudited)

(Audited)

Six months ended

Six months ended

Year ended

31st October 2018

31st October 2017

30th April 2018

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

(Losses)/gains on investments

held at fair value through

profit or loss

-

(442)

(442)

-

1,554

1,554

-

718

718

Net foreign currency

gains/(losses)

-

9

9

-

(25)

(25)

-

(51)

(51)

Income from investments

346

-

346

339

-

339

914

-

914

Interest receivable and

similar income

2

-

2

3

-

3

5

-

5

Gross return/(loss)

348

(433)

(85)

342

1,529

1,871

919

667

1,586

Management fee

(86)

-

(86)

(103)

-

(103)

(226)

-

(226)

Other administrative expenses

(138)

-

(138)

(126)

-

(126)

(304)

-

(304)

Net return/(loss) on ordinary

activities before taxation

124

(433)

(309)

113

1,529

1,642

389

667

1,056

Taxation

(32)

-

(32)

(20)

-

(20)

(68)

-

(68)

Net return/(loss) on ordinary

activities after taxation

92

(433)

(341)

93

1,529

1,622

321

667

988

Return/(loss) per share

(note 3)

0.28p

(1.29)p

(1.01)p

0.28p

4.54p

4.82p

0.95p

1.99p

2.94p

All revenue and capital items in the above statement derive from continuing operations. No operations were acquired or discontinued in the period.

The 'Total' column of this statement is the profit and loss account of the Company and the 'Revenue' and 'Capital' columns represent supplementary information prepared under guidance issued by the Association of Investment Companies.

The net return/(loss) on ordinary activities after taxation represents the profit/(loss) for the period/year and also total comprehensive income.

 

 

 

 

STATEMENT OF CHANGES IN EQUITY

FOR THE SIX MONTHS ENDED 31ST OCTOBER 2018

 

Called up

Capital

share

Share

redemption

Other

Capital

Revenue

capital

premium

reserve

reserve

reserves

reserve 1

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Six months ended 31st October 2018

(Unaudited)

At 30th April 2018

617

16,149

13

26,482

(18,586)

975

25,650

Net (loss)/return from ordinary activities

-

-

-

-

(433)

92

(341)

Dividends paid in the period (note 4)

-

-

-

 -

-

(268)

(268)

At 31st October 2018

617

16,149

13

26,482

(19,019)

799

25,041

Six months ended 31st October 2017

(Unaudited)

At 30th April 2017

617

16,149

13

26,879

(19,253)

924

25,329

Repurchase of shares into Treasury

-

 -

-

(397)

-

-

(397)

Net return from ordinary activities

-

 -

-

-

1,529

93

1,622

Dividends paid in the period (note 4)

-

 -

-

-

-

(270)

(270)

At 31st October 2017

617

16,149

13

26,482

(17,724)

747

26,284

Year ended 30th April 2018

(Audited)

At 30th April 2017

617

16,149

13

26,879

(19,253)

924

25,329

Repurchase of shares into Treasury

-

 -

-

(397)

-

-

(397)

Net return from ordinary activities

-

 -

-

-

667

321

988

Dividends paid in the year (note 4)

-

 -

-

-

-

(270)

(270)

At 30th April 2018

617

16,149

13

26,482

(18,586)

975

25,650

1 This reserve forms the distributable reserve for the Company and may be used to fund distribution of profits to investors via dividend payments.

 

STATEMENT OF FINANCIAL POSITION AT 31ST OCTOBER 2018

 

(Unaudited)

(Unaudited)

(Audited)

31st October 2018

31st October 2017

30th April 2018

£'000

£'000

£'000

Fixed assets

Investments held at fair value through profit or loss

24,775

26,117

25,295

Current assets

Derivative financial assets

1

-

-

Debtors

333

151

134

Cash and cash equivalents

5

149

316

339

300

450

Current liabilities

Creditors: amounts falling due within one year

(73)

(133)

(95)

Net current assets

266

167

355

Total assets less current liabilities

25,041

26,284

25,650

Net assets

25,041

26,284

25,650

Capital and reserves

Called up share capital

617

617

617

Share premium

16,149

16,149

16,149

Capital redemption reserve

13

13

13

Other reserve

26,482

26,482

26,482

Capital reserves

(19,019)

(17,724)

(18,586)

Revenue reserve

799

747

975

Total shareholders' funds

25,041

26,284

25,650

Net asset value per share (note 5)

74.7p

78.4p

76.5p

 

 

 

 

 

 

 

 

 

 

 

STATEMENT OF CASH FLOWS

FOR THE SIX MONTHS ENDED 31ST OCTOBER 2018

 

(Unaudited)

(Unaudited)

(Audited)

Six months ended

Six months ended

Year ended

31st October 2018

31st October 2017

30th April 2018

£'000

£'000

£'000

Net cash outflow from operations before dividends received and interest

(250)

(238)

(539)

Dividends received

348

310

816

Interest received

2

4

6

Net cash inflow from operating activities

100

76

283

Purchases of investments

(3,131)

(5,502)

(10,829)

Sales of investments

2,992

5,537

10,852

Settlement of foreign currency contracts

(4)

(1)

(28)

Net cash (outflow)/inflow from investing activities

(143)

34

(5)

Dividends paid

(268)

(270)

(270)

Repurchase of shares into Treasury

-

(396)

(397)

Net cash outflow from financing activities

(268)

(666)

(667)

Decrease in cash and cash equivalents

(311)

(556)

(389)

Cash and cash equivalents at start of period

316

705

705

Cash and cash equivalents at end of period

5

149

316

Decrease in cash and cash equivalents

(311)

(556)

(389)

Cash and cash equivalents consist of:

Cash and short term deposits

5

149

75

Cash held in JPMorgan US Dollar Liquidity Fund

-

-

241

Total

5

149

316

 

NOTES TO THE FINANCIAL STATEMENTSFOR THE SIX MONTHS ENDED 31ST OCTOBER 2018

1. Financial statements

The information contained within the financial statements in this half year report has not been audited or reviewed by the Company's auditors.

The figures and financial information for the year ended 30th April 2018 are extracted from the latest published financial statements of the Company and do not constitute statutory accounts for that year. Those financial statements have been delivered to the Registrar of Companies and including the report of the auditors which was unqualified and did not contain a statement under either section 498(2) or 498(3) of the Companies Act 2006.

2. Accounting policies

The financial statements have been prepared in accordance with the Companies Act 2006, FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' of the United Kingdom Generally Accepted Accounting Practice ('UK GAAP') and with the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' (the revised 'SORP') issued by the Association of Investment Companies in November 2014 and updated in February 2018.

FRS 104, 'Interim Financial Reporting', issued by the Financial Reporting Council ('FRC') in March 2015 has been applied in preparing this condensed set of financial statements for the six months ended 31st October 2018.

All of the Company's operations are of a continuing nature.

The accounting policies applied to this condensed set of financial statements are consistent with those applied in the financial statements for the year ended 30th April 2018.

 

 

 

 

 

 

3. (Loss)/return per share

(Unaudited)

(Unaudited)

(Audited)

Six months ended

Six months ended

Year ended

31st October 2018

31st October 2017

30th April 2018

£'000

£'000

£'000

(Loss)/return per share is based on the following:

Revenue return

92

93

321

Capital (loss)/return

(433)

1,529

667

Total (loss)/return

(367)

1,622

988

Weighted average number of shares in issue

33,524,854

33,676,349

33,601,224

Revenue return per share

0.28p

0.28p

0.95p

Capital (loss)/return per share

(1.29)p

4.54p

1.99p

Total (loss)/return per share

(1.01)p

4.82p

2.94p

 

 

 

4. Dividends paid

(Unaudited)

(Unaudited)

(Audited)

Six months ended

Six months ended

Year ended

31st October 2018

31st October 2017

30th April 2018

£'000

£'000

£'000

Final dividend in respect of the year ended 30th April 2018 of 0.8p (2017: 0.8p)

268

270

270

All dividends paid in the period/year have been funded from the revenue reserve.

 

 

5. Net asset value per share

(Unaudited)

(Unaudited)

(Audited)

Six months ended

Six months ended

Year ended

31st October 2018

31st October 2017

30th April 2018

Net assets (£'000)

25,041

26,284

25,650

Number of shares in issue

33,524,854

33,524,854

33,524,854

Net asset value per share

74.7p

78.4p

76.5p

 

For further information, please contact:

Divya Amin

For and on behalf of

JPMorgan Funds Limited, Secretary

020 7742 4000

 

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

JPMORGAN FUNDS (UK) LIMITED

ENDS

A copy of the half year will be submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM 

The half year will also shortly be available on the Company's website at www.jpmbrazil.co.uk where up to date information on the Company, including daily NAV and share prices, factsheets and portfolio information can also be found.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR EXLFFVLFEFBV
Date   Source Headline
16th Nov 20202:29 pmRNSGearing Announcement
16th Nov 202012:12 pmRNSNet Asset Value(s)
16th Nov 202012:01 pmRNSResult of Meeting
13th Nov 202011:25 amRNSNet Asset Value(s)
12th Nov 202011:05 amRNSNet Asset Value(s)
11th Nov 20202:01 pmRNSTen Largest Investments
11th Nov 202010:59 amRNSNet Asset Value(s)
10th Nov 202012:33 pmRNSNet Asset Value(s)
10th Nov 20209:15 amRNSGearing Announcement
9th Nov 20205:30 pmRNSJPMorgan Brazil Inv Trust
9th Nov 202011:34 amRNSNet Asset Value(s)
6th Nov 202011:24 amRNSNet Asset Value(s)
5th Nov 202012:18 pmRNSNet Asset Value(s)
4th Nov 202010:41 amRNSNet Asset Value(s)
3rd Nov 202011:28 amRNSNet Asset Value(s)
2nd Nov 202012:06 pmRNSGearing Announcement
2nd Nov 202011:59 amRNSNet Asset Value(s)
30th Oct 202011:42 amRNSNet Asset Value(s)
29th Oct 202011:21 amRNSNet Asset Value(s)
28th Oct 202010:50 amRNSNet Asset Value(s)
27th Oct 202011:10 amRNSNet Asset Value(s)
26th Oct 202012:11 pmRNSGearing Announcement
26th Oct 202011:05 amRNSNet Asset Value(s)
23rd Oct 202010:28 amRNSNet Asset Value(s)
22nd Oct 202012:22 pmRNSNet Asset Value(s)
21st Oct 202011:05 amRNSNet Asset Value(s)
20th Oct 202012:17 pmRNSNet Asset Value(s)
19th Oct 202011:45 amRNSGearing Announcement
19th Oct 202011:00 amRNSNet Asset Value(s)
16th Oct 20205:09 pmRNSPublication and posting of Circular
16th Oct 202011:12 amRNSNet Asset Value(s)
15th Oct 202011:17 amRNSNet Asset Value(s)
14th Oct 202010:27 amRNSNet Asset Value(s)
13th Oct 202011:11 amRNSNet Asset Value(s)
12th Oct 20203:34 pmRNSTen Largest Investments
12th Oct 202011:53 amRNSGearing Announcement
12th Oct 202011:11 amRNSNet Asset Value(s)
9th Oct 202011:03 amRNSNet Asset Value(s)
8th Oct 202010:48 amRNSNet Asset Value(s)
7th Oct 202010:52 amRNSNet Asset Value(s)
6th Oct 202011:53 amRNSNet Asset Value(s)
5th Oct 20202:19 pmRNSGearing Announcement
5th Oct 202012:09 pmRNSNet Asset Value(s)
2nd Oct 202011:49 amRNSNet Asset Value(s)
1st Oct 202012:06 pmRNSNet Asset Value(s)
30th Sep 202011:16 amRNSNet Asset Value(s)
29th Sep 202011:37 amRNSNet Asset Value(s)
28th Sep 202012:13 pmRNSGearing Announcement
28th Sep 202011:33 amRNSNet Asset Value(s)
25th Sep 202011:01 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.